Company ProfilePremium

Nuix Limited

Company Profile Analysis

Ticker: NXL.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Nuix Limited - Company showcase

Year Founded & Workforce

2000

478 Employees

Nuix Limited logo

Nuix Limited Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Nuix Limited Overview

Nuix is an Australian-headquartered developer of forensic-grade unstructured-data intelligence software. Its core asset is a patented parallel-processing engine that ingests, normalises, indexes and enriches very large, messy data sets. The Annual Report 2026 cites up to 1.5TB per hour across more than 1,000 file types, with chain-of-custody defensibility. The company is migrating its installed base from a portfolio of point products (Workstation, Investigate, Discover, Automate/Rampiva, the Engine SDK) to a single browser-based platform, Nuix Neo, sold on a consumption/subscription basis with opt-in AI modules. Neo is now 30% of A$260.0m ACV. Customers are mainly government and law-enforcement agencies (40% of ACV), advisory firms, regulated corporates and law firms; more than 80% of ACV is generated outside Australia. After a disastrous 2020–21 post-IPO period, Nuix has rebuilt credibility. It returned to statutory profit in FY26 and won a clean sweep against ASIC at first instance. It is now repositioning from investigative tooling to an enterprise "governed data layer" for AI.


Company's own description (Annual Report 2026 / Appendix 4E)

In its FY26 Directors' Report, Nuix describes itself as a leading provider of investigative analytics and intelligence software. It says it lets organisations find meaningful insights from large volumes of unstructured data. The platform comprises a proprietary processing engine (the Nuix Engine) plus software applications, developed in-house since 2000 with input from long-standing government and private-sector customers. Nuix stresses that the platform works at a "forensic level", giving users a detailed, contextualised and legally defensible view of the data. The Annual Report 2026 sums up the mission as turning the world's most complex unstructured data into evidence, compliance insight and trustworthy AI. The company's long-running purpose statement is to be "a force for good by finding truth in the digital world."

Independent characterisation

Nuix is best understood as a specialist data-processing infrastructure vendor that sits at the evidentiary front end of high-stakes workflows. Its customers include digital forensics labs in police and intelligence agencies, regulators and integrity commissions, eDiscovery service providers and Big Four/advisory forensic practices, corporate legal and compliance functions, and law firms. Its differentiation lies in speed and scale of processing, breadth of file-format support, and defensibility (repeatable processing profiles, audit trails, court admissibility). It is less differentiated in front-end review UI and analytics, where Relativity, Everlaw, DISCO, Cellebrite, Magnet/Exterro and others compete heavily.

The FY24–FY26 strategy has two parts:

  1. Platform consolidation. Nuix Neo bundles the Engine, automation/orchestration, a collaborative web investigation interface and APIs ("Neo Foundation"), then layers solution packs (Investigations, Legal Discovery, Data Privacy, Custom) and AI enablers on top.

  2. Upward repositioning from an investigations tool to an enterprise unstructured-data governance layer that feeds AI. Management cites a multi-billion-dollar addressable market, more than 10,000 ideal-customer-profile (ICP) accounts, current penetration below 10%, and potential of A$500k+ ACV per ICP account.

Business and revenue model

DimensionFY26 disclosure (FY26 Results Presentation, appendix)
Software vs other revenueSoftware revenue A$246.9m (93.8%); Other revenue A$16.4m (6.2%)
Subscription ACV share97% of total ACV (in line with FY25)
ACV by licence typeSoftware licence module 66%; Consumption 21%; Perpetual maintenance 10%; Perpetual licences 1%; Services (non-Advantage) 2%
Pricing mechanicsModule: annual or multi-year, per core or per user. Consumption: tiered cost per gigabyte processed or under management, often with minimum commitments. Perpetual: one-time per core, usually paired with maintenance.
Multi-year deals (% of revenue)35% in FY26 vs 27% in FY25. Multi-year on-premise subscriptions are largely recognised upfront under AASB 15, which makes revenue lumpier than ACV.
Customer concentrationTop 20 customers 32% of ACV; customers 21–100 34%; remainder 34%; no single customer above 3% of ACV
Customer tenureMore than 10 years: 43% of ACV; 5–10 years: 37%; under 5 years: 20%
ACV by industry (FY26)Government 40%; Advisories 26%; Corporate 25%; Law firms 9%
Geographic exposureMore than 80% of ACV generated outside Australia; North America 54%, EMEA 27%, APAC 19% of ACV

Value-chain position

Nuix sits upstream in the Electronic Discovery Reference Model (EDRM) and the digital-forensics workflow: identification, collection, processing and enrichment. Neo and Discover extend it into review, analysis and production. Linkurious (acquired April 2026) adds graph-based link analysis and decision intelligence for fraud, AML and investigations.

Nuix sells directly and through partners. eDiscovery service providers such as Lighthouse Document Technologies, Noticia and Lineal resell or host Nuix capacity. In FY26 COGS rose partly because of higher sales through partner channels.

End-markets

Law enforcement and national security: digital forensics, intelligence analysis, child-exploitation and organised-crime investigations.

Regulators and integrity agencies: misconduct, corruption and market-abuse investigations.

Legal and eDiscovery: litigation review, regulatory responses, FOI.

Corporate compliance, privacy and security: PII discovery and remediation, breach response, insider-risk investigations, records governance.

Financial crime (expanded via Linkurious): fraud rings, AML networks, beneficial-ownership analysis.

Strategy

Stated strategy (FY26 Results / Annual Report 2026 themes)

Management describes FY26 as a reset of how Nuix builds, positions, sells and embeds the Neo platform, moving "from feature selling to platform value." Five growth pillars underpin it:

  1. Nuix Neo migration. A structured programme moving the component base to Neo, with typical ACV uplift of 30–50%.

    • Phase 1, Foundation & Intelligence (Dec 2025–Jan 2026): economic model validation, ICP definition, readiness assessment.

    • Phase 2, Build Migration Factory (Jan–Mar 2026): playbooks, regional deployment strategies, partner capability.

    • Phase 3, Execution at Scale (Apr 2026–FY30).

  2. ICP upsell: deepening wallet share in high-value accounts with discrete AI modules and graph analytics.

  3. New customers: account-based marketing aimed at the more than 10,000 ICP accounts (regulated large enterprises, 50TB+ of unstructured data, complex compliance, A$500k+ ACV potential).

  4. Discover growth: a dedicated go-to-market team, EVP and R&D.

  5. Partner and geographic expansion: channel-led reach.

Initiatives announced in the last 24 months

InitiativeDateDetail and targets
Nuix Neo migration programmeLaunched Dec 2025Neo to become the majority of ACV in the medium term; 30% at FY26
Linkurious acquisitionAnnounced 4 Dec 2025; closed 20 Apr 2026Graph intelligence; cross-sell into financial crime
Go-to-market realignmentDesigned FY26; operational FY27Two regions (Americas, International) each under an EVP; Chief Customer Officer; Sales Enablement function; dedicated Discover team; Expert Services as revenue enabler; global partner leadership. Essentially cost-neutral apart from about A$4.5–5m of one-off restructuring costs in FY27.
Product & Technology unificationFY26CTO ownership, product operations, embedded design leadership
R&D AcceleratorAnnounced 24 Aug 2026One-off A$15m additional FY27 investment across Enterprise Integration & Connectivity, Agentic AI, Cloud Platform Acceleration, Unified UI/UX and Accelerated Innovation Cadence. Revenue benefit targeted from FY28.
AI strategy (external)FY26Model-agnostic BYO AI, opt-in AI modules, auditability, sovereignty; MCP Server and Neo Agent on the roadmap
AI strategy (internal)FY25–27NuixQ assistant (GA October 2025); AI Builders and AI Champion Network; Digital FTE (dFTE) programme with monthly dFTE targets per function from FY27. Stated aim is to scale capacity rather than cut headcount.
Reflect Reconciliation Action PlanFY26Endorsed by Reconciliation Australia
Mandatory climate disclosuresFrom FY27Group 2 entity under ASRS; first reporting period year ending 30 Jun 2027

Strategic objectives and guidance track record

YearObjectives / guidanceOutcome
FY24About 10% ACV and revenue growth; revenue growth above cost growthExceeded: ACV +14% (+12% constant currency); revenue +20.9%
FY25About 15% ACV growth (constant currency); Neo rollout; revenue growth above cost growth; underlying cash flow positiveMissed on ACV (+8%); revenue flat; underlying cash flow A$20.1m positive
FY26ACV A$240–260m (excl. M&A), raised to A$252–272m including Linkurious; ACV growth driven by Neo; revenue growth above cost growth; underlying cash flow positiveMet: ACV A$260.0m, within range; all objectives delivered
FY27ACV A$285–300m (AUD/USD 0.70 assumption); Adjusted Management EBITDA similar to FY26 (about A$60m) after the A$15m R&D Accelerator; growth weighted to 2HPending

The FY27 ACV guidance implies 9.6–15.4% reported growth. That includes a full year of Linkurious, already in the FY26 exit ACV, so it is effectively all organic plus FX.

Medium-term financial targets (margin or ACV targets beyond FY27) are n.p.d., apart from the qualitative goal of Neo becoming the majority of ACV in the medium term.

Products & Services

Nuix's catalogue is organised here by platform layer, since there are no statutory segments. Launch years reflect the earliest public reference found. "n.p.d." indicates pricing or version not disclosed.

Nuix Neo platform (strategic core)

OfferingDescription and capabilitiesTarget customerLaunch / latestPricing model
Nuix Neo FoundationEntry platform: patented binary processing engine, automation and orchestration, collaborative browser-based investigation interface, Neo platform APIs. Deployable on-premise or in customer cloud; Neo SaaS Foundation is on the roadmap.All segments; positioned as the strategic land offerFY24 launch; Foundation heavily promoted FY25–26Consumption-based subscription with on-demand scalability (Directors' Report FY26)
Neo InvestigationsSolution pack for fraud, misconduct and incident investigations; used by law enforcement and regulatorsPolice, regulators, integrity agencies, corporate investigationsFY24–25Add-on solution; n.p.d.
Neo Legal DiscoveryeDiscovery processing and review workflows on Neo; demand increasing in FY26, especially North AmericaLaw firms, eDiscovery providers, corporate legalFY25–26Add-on solution; n.p.d.
Neo Data PrivacyPII discovery and remediation; first Neo use case, built in FY23 for early-FY24 launchCorporates, government (FOI, privacy compliance)FY24Add-on solution; n.p.d.
Neo Custom SolutionsCustomer-specific workflows built on the same platformLarge ICP accountsFY26n.p.d.
AI enablersBYO AI (customer-preferred LLM), Semantic Search, GenAI document review, GenAI summarisation and case chat, transcription, facial recognition, 500+ NLP models. Expanded in FY26; Neo 2.1 release with semantic search and UI upgrades was due from March 2026 (Morgan Stanley note, Feb 2026).Existing Neo customers (about 20% had bought extra AI enablers by FY26)FY24–26Priced as discrete, opt-in modules
Knowledge graph / graph visualisation (Linkurious technology)Entity resolution and relationship mapping across people, organisations, accounts, transactions and communications; AML and fraud-ring use casesFinancial crime, law enforcement, intelligenceAcquired April 2026Add-on module (about 7% of Neo customers had purchased by FY26)
Neo Agent (Next)User-initiated agentic AI workflows on uploaded data, with every action loggedEnterprise and governmentRoadmap ("Next")n.p.d.
MCP Server (Next)Makes Neo callable from AI assistants and agentic surfaces through the Model Context ProtocolEnterprises building AI stacksRoadmap ("Next")n.p.d.
Nuix AdvantageRenewable consulting/engagement service, minimum 12-month term, counted in Subscription ACVStrategic accountsOngoingSubscription

About 60% of Neo customers had purchased the AI-enriched solutions library by FY26 (FY26 Results Presentation, slide 23). The typical ACV uplift when a component customer migrates to full Neo is 30–50%.

Component (legacy / standalone) products

ProductDescriptionTarget customerStatusPricing
Nuix EngineCore parallel-processing engine; also licensed via SDK/OEM to partnersISVs, service providers, governmentSince 2000s; embedded in NeoPer core / OEM; n.p.d.
Nuix WorkstationDesktop forensic processing and analysis applicationDigital forensics labsMature; migrating to NeoModule (per core/user)
Nuix InvestigateBrowser-based collaborative review for investigatorsLaw enforcement, regulatorsMature; migrating to NeoModule
Nuix Automate / RampivaAutomation and orchestration of processing pipelines (24/7 queues). Rampiva technology was acquired and integrated, and the prior Automate product's amortisation was accelerated in FY25.Labs with high case volumesIntegrated into Neo FoundationModule
Nuix ECC / collection toolsEnterprise collection (identify and collect stage)Corporates, service providersMatureModule; n.p.d.
Other legacy lines (e.g., Data Finder, Adaptive Security endpoint, Enrich)Historical products for data discovery and endpoint securityVariousCurrent commercial status not confirmed in FY26 filingsn.p.d.

Nuix Discover (separately managed franchise from FY27)

AttributeDetail
DescriptionEnd-to-end eDiscovery review platform with AI relevance ranking, native processing, email threading, multitenancy, audio/video review (roadmap); derived from the Ringtail platform
DeploymentOn-premise, customer cloud, Nuix-hosted SaaS (AWS regions: Canada, Germany, Australia, UK, US, Brazil), or partner-hosted SaaS (e.g., Noticia's Canadian data centre)
FY26 performanceOn-premise growth offset by a SaaS decline, driven by the loss of one large SaaS contract (an APAC law-firm account); net -A$2.7m ACV
FY26 wins citedGlobal commodities trader replacing a competitor; major APAC bank choosing on-premise Discover over a key competitor; Canadian law firm migrating to Discover SaaS. Noticia case study cites a 75% eDiscovery cost reduction for a major Canadian law firm.
StrategyNew EVP Discover reporting to the CEO, dedicated sales team, R&D Accelerator funding for UX and agentic features
PricingSaaS consumption (per GB) or module licence; n.p.d.

Linkurious (acquired 20 April 2026)

AttributeDetail
CompanyLinkurious SAS, Paris; founded 2013; CEO Sébastien Heymann (at signing)
OfferingGraph-powered AI decision-intelligence and visualisation platform for exploring graph data, detecting patterns of interest and investigating alerts. Uses include AML, fraud, financial crime, intelligence analysis and cybersecurity.
CustomersNorth America, Europe and APAC, including major financial institutions and regulators, with some joint Nuix customers
FinancialsACV about €7m (about A$12m) at June 2025; positive EBITDA and operating cash flow in CY2024. FY26 contribution: ACV A$12.0m (run-rate), revenue A$3.8m and EBITDA A$2.0m over 72 days.
Go-to-marketSold standalone and as a Neo add-on; full team and Paris office retained

Services and internal platforms

Expert Services: professional services, repositioned in FY27 as a revenue-enabling capability.

Training and certification: offered; pricing not disclosed.

NuixQ: internal AI assistant, not a commercial product. Built on Anthropic technology in partnership with Amazon and generally available since October 2025. It reached a 92% adoption rate among active users and 79,523 automated action invocations by July 2026 (Annual Report 2026).

Financial Narrative

All A$m unless stated. Sources: FY26 Results Presentation (5-year charts and appendix), FY26/FY25/FY24/FY23 Appendix 4E and results releases, Annual Report 2023. Items marked "derived" are calculated from disclosed figures.

Income statement — chartable core

Note: the FY2022 growth cells show 0 as a placeholder because FY21 comparables are on a different (pro forma) basis. Treat them as not applicable. FY22 statutory NPAT of -A$22.791m is from the FY23 Appendix 4E comparative.

Revenue CAGR FY22–FY26 (derived): 14.7%. ACV CAGR FY22–FY26 (derived): 12.6%.

Income statement — items with partial history (non-chart)

FY24 underlying EBITDA of A$64.4m (+38.7%) is per Capital Brief, citing the FY24 release. FY22–23 PBT is from the FY23 Results Presentation (statutory). Gross profit is not separately disclosed in the earlier-year excerpts reviewed.

Balance sheet

FY24 net cash is approximated by reported cash on hand of about A$38m (Capital Brief, Aug 2024); treat it as approximate. FY26 net cash equals cash A$69.9m less debt A$20.1m.

30 June 2026 vs 31 December 2025 balance sheet (FY26 Results Presentation, appendix):

FY25 year-end total equity was about A$290.8m (InvestSMART aggregator; secondary). The goodwill vs other intangibles split is n.p.d. in the excerpts reviewed. The current/non-current classification of contract assets was not disclosed in the excerpts, so working capital and the current ratio cannot be computed precisely (n.p.d.).

Debt facility: A$50m HSBC multicurrency revolving facility, upsized in FY26. A$20.0m was drawn for Linkurious and A$1.337m used for bank guarantees at 30 June 2026 (Annual Report 2026). Maturity date n.p.d.

Cash flow

FY26 free-cash-flow conversion (underlying FCF ÷ Adjusted Management EBITDA) was 85% (FY26 Results Presentation, slide 19).

Trend commentary

Revenue and ACV. FY22 marked the post-IPO trough. ACV fell slightly as new business stalled, and revenue was depressed by fewer multi-year deals. FY23–FY24 saw a recovery under Rubinsztein, with ACV growing about 14% a year and revenue about 20% a year. NDR peaked at 112.9% in FY24.

FY25 was an inflection downward. Revenue was flat (+0.4%) because multi-year deal timing fell to 27% of revenue. ACV grew only 8% against a ~15% constant-currency objective, as churn rose to 7.1% and downsell hit legacy components. FY26 re-accelerated: revenue +18.8% (+17.1% organic, +20.3% organic constant currency), driven by multi-year renewals and Neo. Organic ACV growth of 8.6% (11.1% constant currency) is respectable rather than spectacular. Neo's +A$50.4m was partly cannibalisation, given the -A$28.2m component movement.

Profitability. Adjusted Management EBITDA moved from -A$13.2m (FY22) to A$59.8m (FY26), with margin up about 31 percentage points over four years. Drivers were R&D discipline (total R&D roughly flat in dollars while revenue grew 73%) and G&A restraint. Statutory NPAT is far more volatile. It is weighed down by heavy D&A on previously capitalised software (A$48.7m in FY26) and recurring legacy legal costs of A$8.5–13.0m a year. The FY26 NPAT also benefited from a A$2.9m tax benefit following a favourable tax ruling.

Accounting quality. The capitalised share of R&D fell from 73% (FY22) to about 40% (FY25–26). This is a material conservatism improvement: EBITDA is now less flattered by capitalisation. It also means statutory D&A should keep trending down as the older capitalised base amortises out, a tailwind to future EBIT.

Cash. FY26 cash generation is the standout metric. Underlying cash flow rose 154% to A$51.0m and FCF reached A$37.4m. This is after funding all development spend internally, and despite A$9.3m of net legal payments. Contract assets (A$75.0m) and receivables (A$66.7m) rose sharply, reflecting instalment-billed multi-year deals. Monitor this as a quality-of-revenue indicator.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Income Statement and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Statutory revenue (AUD Mn)

152.3182.5220.6221.5263.2

Revenue growth YoY (%)

019.820.90.418.8

ACV (AUD Mn)

162.0185.5211.5228.4260.0

ACV growth YoY (%)

014.514.08.013.9

Adjusted Management EBITDA, formerly Cash EBITDA (AUD Mn)

-13.26.629.937.259.8

Adjusted Management EBITDA margin (%)

-8.73.613.616.822.7

Statutory EBITDA (AUD Mn; FY22 derived from FY23 +189.2%)

12.134.955.947.666.9

Statutory EBITDA margin (%, derived)

7.919.125.321.525.4

Statutory NPAT (AUD Mn)

-22.8-5.65.0-9.216.4

Net margin (%, derived)

-15.0-3.12.3-4.26.2

Multi-year deals share of revenue (%)

4030312735

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Income Statement and Margin Analysis (%) (FY22–FY26)

MetricFY22FY23FY24FY25FY26

Gross profit (AUD Mn)

n.p.d.

n.p.d.

n.p.d.

199.7236.0

Gross margin (%)

n.p.d.

n.p.d.

n.p.d.

90.189.7

Underlying EBITDA (AUD Mn)

n.p.d.

n.p.d.

64.460.083.2

Net non-operational legal costs (AUD Mn)

n.p.d.

n.p.d.

8.510.613.0

Restructuring costs (AUD Mn)

n.p.d.

n.p.d.

n.p.d.

1.70.5

Acquisition costs (AUD Mn)

00002.8

Depreciation & amortisation (AUD Mn)

n.p.d.

n.p.d.

n.p.d.

55.248.7

EBIT / operating income (AUD Mn)

n.p.d.

n.p.d.

n.p.d.

-7.618.2

Profit before tax (AUD Mn)

-24.1-5.3

n.p.d.

-9.013.5

Income tax benefit/(expense) (AUD Mn)

n.p.d.

n.p.d.

n.p.d.

-0.22.9

EPS basic (A$ cents)

n.p.d.

n.p.d.

n.p.d.

n.p.d.

about 4.9 (derived: NPAT ÷ about 335m average shares)

Dividends per share

00000

Income Statement and Margin Analysis (%) — Total R&D spend

MetricFY2022FY2023FY2024FY2025FY2026

Total R&D spend (AUD Mn)

58.360.053.054.857.8

Capitalised R&D (AUD Mn)

42.439.834.522.723.4

Expensed R&D (AUD Mn)

15.920.218.532.134.3

R&D as % of revenue

3833242522

Capitalised share of R&D (%, derived)

7366654140

Key Financials

MetricFY2022FY2023FY2024FY2025FY2026

Net cash (AUD Mn)

46.829.638.040.049.9

Balance Sheet

Line item (AUD Mn)31 Dec 202530 Jun 2026

Cash and cash equivalents

57.869.9

Trade and other receivables

51.066.7

Contract assets

61.975.0

Other current assets

10.413.4

Property, plant & equipment

3.03.0

Intangibles (goodwill plus capitalised software plus acquired intangibles)

209.5229.9

Deferred tax and lease assets

28.925.8

Total assets

422.4483.8

Trade and other payables

23.037.4

Deferred tax and lease liabilities

23.425.3

Deferred revenue

67.568.3

Debt (HSBC revolver; short/long split n.p.d.)

0.020.1

Provisions

4.46.1

Other liabilities (includes Linkurious deferred/contingent consideration)

1.513.5

Total liabilities

119.8170.6

Issued capital

380.8393.7

Reserves

-141.4-149.1

Retained earnings

63.268.6

Total equity

302.6313.1

Cash Flow

MetricFY23FY24FY25FY26

Net operating cash flow (AUD Mn; secondary, InvestSMART)

35.350.326.9

n.p.d.

Net investing cash flow (AUD Mn; secondary)

-48-38-23

n.p.d.

Underlying cash flow, before non-operational legal, restructuring and M&A (AUD Mn)

n.p.d.

n.p.d.

20.151.0

Overall free cash flow (AUD Mn)

n.p.d.

n.p.d.

4.037.4

Capitalised development (cash capex proxy) (AUD Mn)

39.834.522.723.4

Net non-operational legal payments (AUD Mn)

n.p.d.

n.p.d.

14.89.3

Dividends paid

0000

Share buybacks

0000

Financial Ratios (x)

RatioFY26 valueBasis

ROE

about 5.4%

NPAT 16.4 ÷ average equity (290.8 FY25 secondary; 313.1 FY26)

ROA

about 3.4%

NPAT ÷ closing total assets 483.8 (FY25 total assets n.p.d.)

ROIC

about 4–5%

EBIT 18.2 × (1 – 30%) ÷ (equity 313.1 + debt 20.1 – cash 69.9); approximate, given the tax benefit distortion

Current ratio

n.p.d.

Current/non-current split not available in the excerpts

Debt / equity

0.06x

20.1 ÷ 313.1

Net debt / EBITDA

Net cash (-0.7x statutory EBITDA)

-49.9 ÷ 66.9

Interest coverage (EBIT / finance costs)

about 9.1x

18.2 ÷ 2.0

Asset turnover

0.54x

Revenue 263.2 ÷ total assets 483.8

Cash conversion cycle

n.p.d.

Receivables days about 92 (derived: 66.7 ÷ 263.2 × 365), inflated by late-year deal closures

Revenue by Region

Region (ACV, AUD Mn)FY2025FY2026

North America ACV (AUD Mn)

123.3141.3

EMEA ACV (AUD Mn)

57.871.0

Asia Pacific ACV (AUD Mn)

47.447.8

Total ACV (AUD Mn)

228.4260.0

Geographic Revenue

RegionShare of FY26 ACVReported growth incl. LinkuriousOrganic growthOrganic constant-currency growthKey drivers (FY26 Results Presentation, slide 14)

North America

54%14.6%12.1%16.4%

Strong government agency sales, Neo adoption, stronger corporate sales, Neo Foundation and Legal solution

EMEA

27%22.9%8.4%8.3%

Neo Investigations across law enforcement and regulators; strong new-logo acquisition in Central Europe; Linkurious (Paris) adds disproportionately

Asia Pacific

19%0.9%-0.2%0.6%

Government wins and Neo adoption offset by loss of a key law-firm account (Discover SaaS)

Share Price History

DatePrice (AUD)Note

4 Dec 2020

5.31

IPO price

Jan 2021

11.00

All-time high (Shine Lawyers)

31 May 2021

<3.00

After downgrades

6 Feb 2023

~0.90

Pre-Sheehy judgment (market cap about A$287m)

7 Feb 2023

~1.19

After Sheehy dismissal

Mar 2025

~3.29–3.37

Director purchases

52-week high (to Jul 2026)

3.35

Halo Technologies

2 Jan 2026 (approx.)

1.81

Start of CY2026 (InvestSMART)

2026 low

1.07

CY2026 low (InvestSMART)

4 May 2026

1.545

CEO appointment day

30 Jul 2026

1.24

Market cap about A$420m (Halo)

21 Aug 2026

1.425

Pre-FY26 result close

24 Aug 2026

~1.80–1.86

FY26 result day, up 26–30%

Early Sep 2026

~1.90

Latest verified price (InvestSMART)

Valuation Multiples

MultipleNuix (FY26 actual)Nuix (FY27 guidance-based)Notes

P/E (statutory)

about 39x

n.p.d.

FY26 NPAT A$16.4m includes a A$2.9m tax benefit

EV / Adjusted Management EBITDA

about 9.9x

about 9.9x

FY27 Adjusted EBITDA guided similar to FY26

EV / Statutory EBITDA

about 8.9x

n.p.d.

—

EV / Revenue

about 2.3x

n.p.d.

—

EV / ACV

about 2.3x

about 2.0–2.1x

FY27 ACV guidance A$285–300m

P / Book

about 2.1x

—

Book equity A$313.1m

Dividend yield

0%0%

No dividends since IPO

Analyst Ratings & Targets

BrokerDateRatingTarget (AUD)

Morgan Stanley

24 Feb 2026

Overweight

3.75 (cut from 4.35)

Shaw and Partners

6 Feb 2026

Coverage ceased

—

Consensus

—

8 analysts cover the stock (Simply Wall St, Apr 2026)

Consensus figures n.p.d.

Analyst Conclusions

Management guidance (FY27)

ItemGuidance
ACVA$285–300m (+9.6% to +15.4%), at AUD/USD 0.70
Adjusted Management EBITDASimilar to FY26's A$59.8m, including the one-off A$15m R&D Accelerator. Implies about A$75m of underlying run-rate before the Accelerator (derived).
PhasingGrowth weighted to the second half, as in prior years
DriversNeo migration at established cadence; renewal book; upsell attach rates; new customers
One-offsAbout A$4.5–5m restructuring cost in FY27, excluded from Adjusted Management EBITDA

Consensus FY27/FY28 forecasts are n.p.d. in the sources reviewed.

Bull case

  1. The migration flywheel is underpriced. About A$169.5m of component and Discover ACV remains (derived). At a 30–50% uplift, full migration could add roughly A$50–85m of ACV over FY27–FY30 before any new logos. That is at an EV/ACV multiple near 2x.

  2. Operating leverage is proven and should resume. The margin rose about 6 percentage points in FY26. Once the A$15m Accelerator rolls off in FY28, Adjusted Management EBITDA could step up sharply on 10–15% ACV growth with flat-to-modest cost growth. FCF conversion of 85% supports a cash-yield valuation.

  3. The legal overhang is shrinking. The directors' ASIC exoneration is final. The company-level appeal has to overturn a comprehensive first-instance judgment. A favourable class-action judgment would remove the last major discount factor.

Bear case

  1. Organic growth is mediocre. Organic ACV grew 8.6% (11.1% constant currency) and NDR has fallen three years running (112.9% to 105.2%). Neo growth may largely be repricing the existing base rather than winning share.

  2. Class-action tail risk. An adverse Victorian judgment could create a liability that is material relative to a market cap of about A$640m. The A$10m insurance retention increases Nuix's net share of any loss.

  3. AI commoditisation and competition. Generative AI and Microsoft Purview could compress pricing for processing and review. FY26 already showed downsell from competitive displacement and pricing decisions, and the loss of a large Discover SaaS account.

Key catalysts and monitorables (next 12 months)

November 2026 AGM: trading update: 1Q27 ACV trajectory against A$285–300m guidance; new NED appointment.

Victorian class-action judgment: (timing unknown): the most important binary event.

ASIC appeal: hearing date and outcome.

1H27 result (about February 2027): - Neo ACV (base A$78.5m; watch for above A$100m).

  • NDR recovery above 105%.

  • Churn back toward about 5%.

  • Discover stabilisation.

  • Linkurious earnout trajectory.

R&D Accelerator delivery: Neo SaaS, MCP Server and Neo Agent releases; Discover UX refresh.

Macquarie intentions: any sell-down, block trade or strategic review, especially with a nominee now on the board.

Capital allocation: further tuck-in M&A using A$30m of undrawn facility and net cash; any first dividend or buyback discussion (unlikely near term).

FX: AUD/USD versus the 0.70 guidance assumption.

Analyst verdict

Nuix in October 2026 is a materially better business than the one that collapsed after its 2020 float. It is still not a fully de-risked one.

The FY26 numbers are genuinely good. Revenue grew 18.8% to A$263.2m. Adjusted Management EBITDA rose 60% to A$59.8m at a 22.7% margin, and statutory profit of A$16.4m was earned on more conservative capitalisation practices. Underlying cash flow of A$51.0m funded all development spend and the Linkurious deal, and still lifted net cash to A$49.9m. Nuix Neo has moved from concept to 30% of ACV in under three years, and its migration economics (30–50% uplift) give visible, largely self-generated growth.

The caveats are equally clear. Strip out Linkurious and FX, and organic ACV growth is about 11%. NDR has fallen for two years and churn is above FY24 levels. Much of Neo's growth is migration of the existing base rather than share gain. Management is also asking investors to accept a flat EBITDA year in FY27 to fund a one-off A$15m R&D push whose payoff is pencilled in for FY28. That request is easier to grant to a new CEO with a clean first-year record than to the Nuix of 2021, but it remains a request.

The legal cloud has thinned rather than lifted. The ASIC win was emphatic, yet the company-level appeal and the reserved class-action judgment keep a tail risk in the valuation, made heavier by the A$10m insurance retention.

At roughly 2x EV/ACV and about 10x Adjusted EBITDA, with net cash, the stock already discounts a lot of this risk. Our synthesis is a constructive but event-driven stance. The investment case hinges on Neo sustaining A$40–50m of net new ACV a year, NDR recovering above 108%, and a non-catastrophic class-action outcome. Delivery on those three would warrant a material re-rating. Failure on any one would likely keep the shares range-bound.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleAppointedIndependenceBackground (Annual Report 2026)Shares held

Robert Mactier

Non-Executive Chairman

Director Oct 2021; Chair Feb 2023

Independent

NED at Iress (since Oct 2024) and Kinetic IT; consultant to UBS Australia advisory/capital markets (since 2007); former Chair of ALE Property Group and WPP AUNZ; former NED of Melco Resorts; early career at KPMG, then Ord Minnett, E.L. & C. Baillieu, Citigroup. BEc (Sydney).

300,000 (bought 75,000 at A$1.855 on 5 Mar 2026)

John Ruthven

CEO & Managing Director

Interim CEO 3 Nov 2025; CEO and director 4 May 2026

Executive

Former CEO & MD of Integrated Research (ASX: IRI) 2019–2024; senior roles at TechnologyOne, SAP (ANZ President/MD), Zuora (SVP International Sales), CA Technologies. Undergraduate studies at Avondale College (MarketScreener); B.Ed, MAICD (Simply Wall St). Brisbane-based.

Nil per Annual Report 2026

Sir Iain Lobban KCMG CB

Non-Executive Director

Adviser Oct 2018; NED Nov 2020

Independent

Director of GCHQ 2008–2014; adviser on Australia's 2015 Cyber Security Strategy and 2017 Intelligence Review. BA (Leeds). Retiring at the November 2026 AGM; will remain an adviser.

Nil

Jacqueline Korhonen

Non-Executive Director

Oct 2021

Independent

23 years at IBM; former CEO of Infosys ANZ and SMS Management & Technology; NED at MyState Bank and Bapcor; formerly CASA board (2023–Feb 2026). BSc/BE (Hons) Sydney; FAICD.

32,258

Alan Cameron AO

Non-Executive Director

Jan 2023

Independent

Former Chair of ASC/ASIC; former Commonwealth Ombudsman; former managing partner of the firm now Ashurst Perkins Coie; former PEXA Chair; former NSW Law Reform Commission Chair. BA, LLM (Sydney).

23,800

Sara Watts

Non-Executive Director

Jan 2023

Independent

Former CFO of IBM ANZ; former Vice-Principal Operations, University of Sydney; NED at Syrah Resources; Sydney Opera House Trust; NACC audit committee. FCPA, FAICD; MBA.

12,158 (bought Mar 2025 at A$3.29)

Rachel Barger

Non-Executive Director

1 Mar 2026

Independent

Chief Revenue Officer at Epicor; former President Go-To-Market at UKG; SVP roles at Cisco; President SE Asia and APAC COO at SAP; former NED of CSG Systems. MBA (AGSM); BChemEng (Delaware). US-based.

Nil

Edward (Ted) Pretty

Non-Executive Director

1 Mar 2026

Non-independent (Macquarie Capital nominee)

Former Telstra Group MD Technology & Product; Chair of Firmus and Dubber; former Chair of NextDC, RP Data, Fujitsu Australia, Tech Mahindra ANZ. LLB (Hons)/BA (Econ), Macquarie University.

Nil

Executive Leadership Team

NameTitleTenure / notesDisclosed compensation

John Ruthven

CEO & MD

Interim from 3 Nov 2025; permanent from 4 May 2026

Fixed remuneration A$900,000 a year, plus STIP and LTIP effective 1 Jul 2026, Brisbane–Sydney accommodation and travel support, and a possible discretionary bonus for the interim period (ASX release, 4 May 2026). FY26 statutory total: see Remuneration Report (n.p.d. in excerpts reviewed).

Peter McClelland

Chief Financial Officer

About 1.4 years as of Apr 2026 (Simply Wall St)

A$619k (Simply Wall St; likely FY25 partial year; secondary)

Alexis Rouch

Chief Technology Officer; owns unified Product & Technology from FY26

About 2.3 years

n.p.d.

Ilona Meyer

General Counsel and EVP Discover (from 6 Jul 2026); Company Secretary until 6 Jul 2026

Joined Aug 2022; ex-Boehringer Ingelheim, ResMed, Medtronic, 3M

n.p.d.

Michael Smith

EVP Americas

About 3.8 years

A$1.22m (Simply Wall St; secondary)

Warren Brugger

EVP APAC & Global Alliances (role likely evolving under the FY27 International structure)

About 3.4 years

A$0.905m (Simply Wall St; secondary)

Sarah Nichols

Chief Strategy & Transformation Officer

About 1.3 years

n.p.d.

Jacqui Levings

Chief People Officer

About 3.3 years

n.p.d.

Nicholas Vesic

Company Secretary (from 6 Jul 2026)

Joined Jun 2024; ex-Macquarie Technology Group, WiseTech, King & Wood Mallesons

n.p.d.

Brett Dimon

Head of Investor Relations & Sustainability

Long-serving IR head

n.p.d.

Chief Customer Officer; EVP International

New FY27 roles

Named in FY26 presentation; incumbents n.p.d.

n.p.d.

Board & Management Changes

DateChangeContext

Late 2024 (approx.)

Peter McClelland becomes CFO

Exact date n.p.d.

Late Oct 2025

Rubinsztein to step down effective 31 Oct 2025

Board said Nuix was stable and it was time for new leadership for the next growth phase, following the FY25 ACV miss

3 Nov 2025

Ruthven interim CEO

Global search launched

4 May 2026

Ruthven permanent CEO & MD

Unanimous board decision after the global search

FY26

Product and Technology unified under the CTO

Part of the strategic reset

6 Jul 2026

Meyer to EVP Discover; Vesic Company Secretary; group restructure communicated

FY27 go-to-market realignment

Major Shareholders

HolderSharesStakeSource / date

Macquarie Group Limited and controlled bodies

96,306,83029.76%

InvestSMART substantial holder register (latest notice). Market Index shows 95.65m (29.75%) as at 5 Sep 2023.

Australian Ethical Investment Ltd

16,875,771 at initial notice

5.10% initial; changes lodged 26 Aug 2026 and 2 Sep 2026

TipRanks/ASX; current level n.p.d.

ECP Asset Management / EC Pohl & Co

n.p.d.

5.22% at notice (date not captured)

TipRanks/ASX

Unidentified holder

n.p.d.

Ceased to be substantial holder, 1 Sep 2026

InvestSMART announcements list

Competitive Landscape

Competitors by Segment

DomainCompetitorOwnershipPositioning vs Nuix

eDiscovery review / legal

Relativity (RelativityOne)

Private (Silver Lake)

Dominant legal-review platform with a large partner ecosystem; Nuix competes on processing and in the Discover segment

eDiscovery (cloud-native)

Everlaw

Private

Cloud-native review with strong mid-market law-firm traction; pressure on Discover SaaS

eDiscovery (cloud-native)

DISCO (CS Disco)

NYSE: LAW

AI-forward legal SaaS; smaller and loss-making

eDiscovery / forensics

Exterro (incl. FTK / AccessData)

Private (Leeds Equity)

Directly competes in forensics processing and legal governance

eDiscovery / review

Reveal (incl. Brainspace)

Private

AI-led review; competes in advisory and service-provider channels

Digital forensics (mobile / law enforcement)

Cellebrite

NASDAQ: CLBT

Leader in mobile extraction and investigations software for law enforcement; overlaps with Neo Investigations

Digital forensics

Magnet Forensics (Magnet AXIOM / Griffeye)

Private (Thoma Bravo since 2023)

Strong in law-enforcement forensic analysis; overlaps with Workstation and Investigate

Enterprise information / eDiscovery

OpenText (EnCase, Axcelerate)

NASDAQ/TSX: OTEX

Broad suite; legacy EnCase installed base competes in forensics

Compliance / privacy

Microsoft Purview (eDiscovery Premium)

Microsoft

"Good-enough" native M365 eDiscovery is a structural threat at the low end

Data privacy / DSPM

BigID, Varonis, Securiti

Private / NASDAQ: VRNS

Compete with Neo Data Privacy and enterprise data-governance positioning

Intelligence / link analysis

Palantir (Gotham), i2 Analyst's Notebook (Harris), Quantexa, Cambridge Intelligence, Neo4j

Mixed

Compete with Linkurious and graph intelligence

Peer Comparison FY2026

MetricNuix (FY26, A$)Cellebrite (FY2024, US$)DISCO (FY2024, US$)OpenText (FY2025, US$)

Revenue

A$263.2m

about US$401m

about US$145m

about US$5.2bn

Revenue growth

18.8%

about 25%

about 5%

Negative (divestitures)

Profitability

Adj. Mgmt EBITDA margin 22.7%; NPAT margin 6.2%

Adjusted EBITDA margin about 20%+

Adjusted EBITDA negative

Adjusted EBITDA margin about 35%

R&D intensity

22% of revenue (total incl. capitalised)

n.p.d. here

n.p.d. here

about 13–15%

Recent Developments

--

Company Snapshot

478

Employees

2000

Founded

Sydney, Australia

Headquarters

SWOT Analysis

Strengths

  • Neo traction: Neo ACV up 179% to A$78.5m across 135 customers (from 75); 30% of ACV (FY26 Results).
  • Margin expansion: Adjusted Management EBITDA margin rose from -8.7% (FY22) to 22.7% (FY26) as total R&D held at A$53–60m.
  • Cash generation: underlying cash flow A$51.0m (+154%); FCF A$37.4m; FCF conversion 85% (FY26).
  • Recurring, diversified base: 97% subscription ACV; no customer above 3% of ACV; top 20 customers at 32%.
  • Tenure and stickiness: 43% of ACV from customers of more than 10 years' tenure; 40% of ACV from government.
  • Clean balance sheet: A$49.9m net cash; debt/equity 0.06x; A$30m undrawn facility.
  • Credential moat: IRAP PROTECTED, ISO 27001:2022/27017/27018, SOC 2 Type 2 maintained in FY26.

Weaknesses

  • Low organic growth beneath the headline: organic ACV +8.6% reported (+11.1% constant currency). Component ACV fell A$28.2m in FY26.
  • Weakening NDR: NDR fell from 112.9% (FY24) to 105.2% (FY26); churn of 6.6% is above FY24's 4.4%.
  • APAC stagnation: organic ACV -0.2% in FY26 after a key law-firm loss.
  • Discover SaaS erosion: -A$2.7m net Discover ACV, including the loss of one large SaaS contract.
  • Statutory earnings quality: FY26 NPAT of A$16.4m includes a A$2.9m tax benefit. D&A of A$48.7m and recurring legal costs (A$13.0m) depress EBIT.
  • Revenue lumpiness: multi-year deals swing between 27% and 40% of revenue, which drove FY25's flat revenue (+0.4%).

Opportunities

  • Migration uplift: a 30–50% ACV uplift on migrating component customers. About A$169.5m of non-Neo, non-Linkurious ACV remains (derived).
  • AI module attach: only about 20% of Neo customers have bought additional AI enablers and about 7% graph visualisation (FY26 slide 23).
  • ICP greenfield: more than 10,000 ICP accounts at below 10% penetration, with A$500k+ ACV potential each.
  • Linkurious cross-sell into financial crime and AML, with early wins already secured.
  • Data sovereignty and AI auditability as structural tailwinds: BYO AI and an MCP Server on the roadmap.
  • Operating leverage from internal AI: NuixQ at 92% adoption; the dFTE programme from FY27.

Threats

  • Class action: Victorian Supreme Court judgment reserved after an 8-week trial ending September 2026. Damages, if any, are unquantified.
  • ASIC appeal against the company is pending in the Full Federal Court.
  • Insurance: an A$10m (not A$2.5m) retention was upheld on 6 July 2026, raising net legal exposure.
  • Competition: FY26 downsell was linked to competitive displacement and pricing (FY26 slide 13). Microsoft Purview is bundling eDiscovery.
  • Concentrated control: Macquarie at 29.76% plus a board nominee creates overhang and sell-down risk, with possible strategic-control implications.
  • Cyber and AI risk: the company explicitly flags that rapid progress in frontier AI models increases the likelihood of cyber events (Annual Report 2026, risk 4).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Mar 2025 (context)Directors Bleich and Watts buy shares at about A$3.29–3.37Insider confidence before the FY25 miss
2025 (date n.p.d.)Investor Day 2025: Neo ACV +132%, total ACV +8%, Cash EBITDA +24.5% (Quartr summary)Strategy re-articulated
Aug 2025Primary judgment in *Nuix v Berkshire Hathaway Specialty Insurance* [2025] FCA 1002 on D&O retentionHigher insurance retention (A$10m) applies to the combined Side B/C claim
25 Aug 2025FY25 results: revenue A$221.5m (+0.4%), ACV A$228.4m, statutory NPAT -A$9.2m, Neo ACV A$28.1m, 75 customersACV objective missed; share price de-rating continued
Oct 2025NuixQ internal AI assistant generally availableInternal AI productivity programme begins
Late Oct 2025Rubinsztein to step down (effective 31 Oct); Ruthven named interim CEOLeadership transition
3 Nov 2025Ruthven starts as interim CEOStrategic review of go-to-market and AI
19 Nov 2025AGM; trading update; Bleich retires; company says the ASIC judgment is not expected before early 2026Governance refresh
4 Dec 2025Linkurious agreement (up to €20m EV); facility upsized to A$50mFirst M&A in years; graph capability
Dec 2025–Mar 2026Neo migration programme Phases 1–2 completedIndustrialised migration
6 Feb 2026Shaw and Partners ceases coverageReduced sell-side coverage
~24 Feb 20261H26: ACV A$234.4m (+8.4%), revenue A$121.2m (+15.2%), NPAT A$11.1m, Neo ACV A$46.8m (+148%), 101 customers; FY26 guidance A$240–260m reaffirmedReturn to profit; Morgan Stanley Overweight, target trimmed to A$3.75
1 Mar 2026Barger and Pretty join the boardUS go-to-market expertise and a Macquarie nominee
5 Mar 2026Chair Mactier buys 75,000 shares at A$1.855Insider buying at depressed levels
Mar 2026Neo 2.1 release (semantic search, UI) scheduled to beginProduct cadence
20 Apr 2026Linkurious financial close; FY26 ACV guidance A$252–272mAcquisition completed
23 Apr 2026Federal Court dismisses all ASIC claims ([2026] FCA 490, Goodman J); trading halt beforehandMajor overhang removed for directors; company appeal risk remains
4 May 2026Ruthven appointed permanent CEO & MD (A$900k fixed pay)Stability; shares +3.7% on the day
21 May 2026ASIC files appeal against the company onlyResidual legal overhang
Jun 2026Sir Iain Lobban's retirement at the November 2026 AGM announcedBoard renewal; NED search
6 Jul 2026Restructure communicated (about A$5m cost in FY27); Meyer becomes EVP Discover; Vesic becomes Company SecretaryGo-to-market realignment
6 Jul 2026Full Federal Court dismisses Nuix's insurance appeal ([2026] FCAFC 87); costs ordered against Nuix; provision recognised (amount undisclosed)Higher net legal cost exposure
Jul–Sep 2026Victorian Supreme Court class-action trial (about 8 weeks) concludes; judgment reserved, no timetableLargest remaining binary legal risk
21 Jul 2026Release of shares from voluntary escrowMinor supply event
24 Aug 2026FY26 results: revenue A$263.2m (+18.8%), ACV A$260.0m, NPAT A$16.4m, underlying cash flow A$51.0m; FY27 guidance ACV A$285–300m; A$15m R&D AcceleratorShares up from A$1.425 to about A$1.80–1.86
26 Aug and 2 Sep 2026Australian Ethical changes its substantial holdingRegister rotation after the result
1 Sep 2026A holder ceases to be a substantial holderProfit-taking after the rally (shares about A$1.90–2.02)
6 Sep 2026Annual Report 2026 lodged (release dated 6 September; the ASX document path suggests 6 October; discrepancy noted)Full Remuneration Report and governance disclosures
Nov 2026 (upcoming)2026 AGM; Sir Iain Lobban retiresWatch for a trading update against FY27 guidance

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

2 charts
Income Statement: Revenue & Gross Profit: Statutory revenue rose from AUD 152.3 Mn in FY2022 to AUD 263.2 Mn in FY2026.
Nuix Limited — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Statutory revenue152.3182.5220.6221.5263.2
Gross profit———199.7236
R&D as % of revenue3833242522

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Nuix, *Nuix Neo momentum underpins strong FY26 result* (ASX release, 24 Aug 2026) (announcements.asx.com.au)
  2. Nuix, *FY26 Financial Results Presentation* (24 Aug 2026) (announcements.asx.com.au)
  3. Nuix, *FY26 Appendix 4E* (announcements.asx.com.au)
  4. Nuix, *Annual Report 2026* (announcements.asx.com.au)
  5. Nuix, *CEO & Managing Director Appointment* (4 May 2026) (announcements.asx.com.au)
  6. Nuix, *Federal Court dismisses ASIC's market disclosure allegations* (23 Apr 2026) (announcements.asx.com.au)
  7. Nuix, *Completion of Linkurious acquisition and updated FY ACV guidance* (20 Apr 2026) (announcements.asx.com.au)
  8. Nuix, *Nuix to Acquire Graph Intelligence Leader Linkurious* (4 Dec 2025) (announcements.asx.com.au)
  9. Nuix, *Chairman and Interim CEO Addresses, Trading Update* (19 Nov 2025) (announcements.asx.com.au)
  10. Nuix, *FY25 Results* (25 Aug 2025) (announcements.asx.com.au)
  11. Nuix, *FY24 Results* (19 Aug 2024) · FY24 Full Year Report
  12. Nuix, *FY23 Appendix 4E* · FY23 Results Presentation · Annual Report 2023
  13. Federal Court of Australia, *ASIC v Nuix Limited* [2026] FCA 490 (judgments.fedcourt.gov.au)
  14. ASIC media release 26-080MR (asic.gov.au)
  15. Techpartner.news, *ASIC appeals Federal Court decision dismissing case against Nuix* (21 May 2026) (techpartner.news)
  16. Ashurst, *When Every Claim Falls Away: Key Lessons from ASIC v Nuix* (ashurst.com)
  17. Colin Biggers & Paisley, *ASIC v Nuix* (11 May 2026) (cbp.com.au)
  18. Supreme Court of Victoria, *Nuix group proceeding* (supremecourt.vic.gov.au)
  19. Federal Court, *Sheehy v Nuix Pty Ltd* [2023] FCA 56 (judgments.fedcourt.gov.au)
  20. Motley Fool Australia (FY26 result, CEO appointment, Sheehy judgment) · fool.com.au · fool.com.au
  21. InvestSMART NXL pages (prices, substantial holders, announcements list) (investsmart.com.au)
  22. FNArena broker summary (Morgan Stanley, Shaw and Partners) (fnarena.com)
  23. Simply Wall St, Nuix management (simplywall.st)
  24. Capital Brief (FY24 result; Linkurious; CEO) (capitalbrief.com)
  25. SmallCaps, *Nuix Reports Strong 1H26* (smallcaps.com.au)
  26. Startup Daily, IPO coverage (Dec 2020) (corestage-cdn.startupdaily.net)
  27. Shine Lawyers, Nuix class action (shine.com.au)
  28. Market Index, NXL profile (marketindex.com.au)
  29. Halo Technologies, NXL snapshot (Jul 2026) (halo-technologies.com)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.